other glp-1 medications List of Receptor Agonists for Diabetes & Weight Loss The GLP-1 Agonists and Obesity:
Description
Successful diabetes care requires a systematic approach to supporting patients behavior change efforts

The sequence similarity for each protein between SNUG-61027 and ATCC-BAA-835 was analyzed

Research shows that GLP-1 medications paired with growth hormone-releasing peptides like Sermorelin can help preserve muscle mass during weight loss

Retrieved March 10, 2026, from The four states that removed coverage of GLP-1 AOMs for weight loss collectively spent approximately $2.5 billion on Wegovy, Zepbound, and Saxenda in a 30-month span, on a gross basis for all indications
This study used only deidentified patient records and therefore did not require institutional review board approval or patient consent in accordance with the Common Rule
